These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34090829)

  • 1. Inter-method variability of hepatitis B surface antigen quantification in a cohort of Egyptian patients with chronic hepatitis B virus.
    Nasser M; Zayed N; Gamal Eldeen H; Abdo M; Kabara Y; Elserafy M
    Arab J Gastroenterol; 2021 Jun; 22(2):151-157. PubMed ID: 34090829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the elecsys HBsAg II assay and the architect assay for quantification of hepatitis B surface antigen in chronic hepatitis B patients.
    Liao CC; Hsu CW; Gu PW; Yeh CT; Lin SM; Chiu CT
    Biomed J; 2015; 38(3):250-6. PubMed ID: 25355387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of hepatitis B surface antigen and E antigen: correlation between Elecsys and architect assays.
    Zhou B; Liu M; Lv G; Zheng H; Wang Y; Sun J; Hou J
    J Viral Hepat; 2013 Jun; 20(6):422-9. PubMed ID: 23647959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between Elecsys HBsAg II and architect HBsAg QT assays for quantification of hepatitis B surface antigen among patients coinfected with HIV and hepatitis B virus.
    Maylin S; Boyd A; Delaugerre C; Zoulim F; Lavocat F; Simon F; Girard PM; Lacombe K
    Clin Vaccine Immunol; 2012 Feb; 19(2):242-8. PubMed ID: 22190396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum.
    Wursthorn K; Jaroszewicz J; Zacher BJ; Darnedde M; Raupach R; Mederacke I; Cornberg M; Manns MP; Wedemeyer H
    J Clin Virol; 2011 Apr; 50(4):292-6. PubMed ID: 21273117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between Elecsys HBsAg II and Architect assays for quantification of serum hepatitis B surface antigen in Chinese patients with chronic hepatitis B.
    Liu WW; Wang AZ; Xie FY; Hu TT; Zhong Q; Huang S
    Clin Lab; 2015; 61(1-2):141-7. PubMed ID: 25807647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of hepatitis B e antigen between Elecsys HBeAg and Architect HBeAg assays among patients infected with hepatitis B virus.
    Maylin S; Boyd A; Martinot-Peignoux M; Delaugerre C; Bagnard G; Lapalus M; Zoulim F; Lavocat F; Marcellin P; Simon F; Girard PM; Lacombe K
    J Clin Virol; 2013 Apr; 56(4):306-11. PubMed ID: 23369885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilution.
    Liu TW; Yeh ML; Huang CF; Lin IL; Huang JF; Dai CY; Chen YL; Chuang WL; Yu ML
    Kaohsiung J Med Sci; 2015 Jan; 31(1):26-33. PubMed ID: 25600917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.
    Boyd A; Maylin S; Moh R; Mahjoub N; Gabillard D; Eholié SP; Danel C; Anglaret X; Zoulim F; Girard PM; Delaugerre C; Lacombefor K;
    J Gastroenterol Hepatol; 2016 Mar; 31(3):634-44. PubMed ID: 26313291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Elecsys HBsAg II Assay and the Architect Assay for Quantification of hepatitis B surface antigen in patients with chronic hepatitis B.
    Karagoz E; Selek MB; Tanoglu A; Hatipoglu M; Ulçay A; Turhan V
    Infez Med; 2016 Dec; 24(4):287-292. PubMed ID: 28011963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hepatitis B in pregnant women: is hepatitis B surface antigen quantification useful for viral load prediction?
    Fujiko M; Chalid MT; Turyadi ; Ie SI; Maghfira ; Syafri ; Wahyuni R; Roni M; Patellongi I; Massi MN; Muljono DH
    Int J Infect Dis; 2015 Dec; 41():83-9. PubMed ID: 26571304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capabilities of hepatitis B surface antigen are divergent from hepatitis B virus DNA in delimiting natural history phases of chronic hepatitis B virus infection.
    Zhang Z; Lu W; Huang D; Zhou X; Ding R; Li X; Wang Y; Lin W; Zeng D; Feng Y
    Front Immunol; 2022; 13():944097. PubMed ID: 35958621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
    Park H; Lee JM; Seo JH; Kim HS; Ahn SH; Kim DY; Han KH; Chon CY; Park JY
    Liver Int; 2012 May; 32(5):796-802. PubMed ID: 22128792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B.
    Demirören K; Kocamaz H; Doğan Y
    Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
    Thompson AJ; Nguyen T; Iser D; Ayres A; Jackson K; Littlejohn M; Slavin J; Bowden S; Gane EJ; Abbott W; Lau GK; Lewin SR; Visvanathan K; Desmond PV; Locarnini SA
    Hepatology; 2010 Jun; 51(6):1933-44. PubMed ID: 20512987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of two assays for quantification of Hepatitis B surface Antigen in patients with chronic hepatitis B.
    Sonneveld MJ; Rijckborst V; Boucher CA; Zwang L; Beersma MF; Hansen BE; Janssen HL
    J Clin Virol; 2011 Jul; 51(3):175-8. PubMed ID: 21592855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between hepatitis B virus DNA levels and diagnostic tests for HBsAg, HBeAg, and PreS1-Ag in chronic hepatitis B.
    Liu X; Chen JM; Lou JL; Huang YX; Yan Y; Sun GZ; Li N
    Genet Mol Res; 2016 Jul; 15(2):. PubMed ID: 27421011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M; Mutlu B; Erdoğan S; Meriç M; Willke A
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with serum hepatitis B surface antigen levels and its on-treatment changes in patients under lamivudine therapy.
    Chen J; Wang Z; Zhou B; Wang Y; Hou J
    Antivir Ther; 2012; 17(1):71-9. PubMed ID: 22267471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between serum HBV DNA level and HBsAg titer in HBeAg-positive pregnant women and impact of genomic variability of hepatitis B virus pre S/S regions on their correlations].
    Zhang X; Yan L; Lu Y; Wei KP; Liu ZX; Xiao YW; Ding F; Zhuang H; Li J
    Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):579-584. PubMed ID: 30317788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.